NAC provides a minimally invasive zirconia pretreatment, particularly for RBFDPs fabricated from damage-prone translucent zirconia, mitigating mechanical failures while maintaining long-term retention comparable to APA.
Malgaj et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: